BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8134106)

  • 1. Functional aspects of B-Myb in early Xenopus development.
    Bouwmeester T; van Wijk I; Wedlich D; Pieler T
    Oncogene; 1994 Apr; 9(4):1029-38. PubMed ID: 8134106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional regulation by the carboxyl terminus of c-Myb depends upon both the Myb DNA-binding domain and the DNA recognition site.
    Dubendorff JW; Lipsick JS
    Oncogene; 1999 Jun; 18(23):3452-60. PubMed ID: 10376523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of B-Myb during mouse embryogenesis.
    Sitzmann J; Noben-Trauth K; Kamano H; Klempnauer KH
    Oncogene; 1996 May; 12(9):1889-94. PubMed ID: 8649849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XLPOU-60, a Xenopus POU-domain mRNA, is oocyte-specific from very early stages of oogenesis, and localised to presumptive mesoderm and ectoderm in the blastula.
    Whitfield T; Heasman J; Wylie C
    Dev Biol; 1993 Feb; 155(2):361-70. PubMed ID: 8432392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-Myb function can be markedly enhanced by cyclin A-dependent kinase and protein truncation.
    Lane S; Farlie P; Watson R
    Oncogene; 1997 May; 14(20):2445-53. PubMed ID: 9188859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.
    Bessa M; Saville MK; Watson RJ
    Oncogene; 2001 Jun; 20(26):3376-86. PubMed ID: 11423988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-Myb repressor function is regulated by cyclin A phosphorylation and sequences within the C-terminal domain.
    Petrovas C; Jeay S; Lewis RE; Sonenshein GE
    Oncogene; 2003 Apr; 22(13):2011-20. PubMed ID: 12673206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal patterns of A-myb and B-myb gene expression during testis development.
    Latham KE; Litvin J; Orth JM; Patel B; Mettus R; Reddy EP
    Oncogene; 1996 Sep; 13(6):1161-8. PubMed ID: 8808690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the Tcf-3 promoter during early development of Xenopus.
    Spieker N; Peterson J; Reneman S; Destrée O
    Dev Dyn; 2004 Nov; 231(3):510-7. PubMed ID: 15376330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An alternatively spliced isoform of B-Myb is a transcriptional inhibitor.
    Horstmann S; Ferrari S; Klempnauer KH
    Oncogene; 2000 Nov; 19(48):5428-34. PubMed ID: 11114719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M; Boss GR; Pascual FE; Pilz RB
    Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure of the B-Myb DNA-binding domain: a possible role for conformational instability of the protein in DNA binding and control of gene expression.
    McIntosh PB; Frenkiel TA; Wollborn U; McCormick JE; Klempnauer KH; Feeney J; Carr MD
    Biochemistry; 1998 Jul; 37(27):9619-29. PubMed ID: 9657674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Myb function in fibroblasts.
    Bein K; Husain M; Ware JA; Mucenski ML; Rosenberg RD; Simons M
    J Cell Physiol; 1997 Dec; 173(3):319-26. PubMed ID: 9369944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A conserved element in the protein-coding sequence is required for normal expression of replication-dependent histone genes in developing Xenopus embryos.
    Ficzycz A; Kaludov NK; Lele Z; Hurt MM; Ovsenek N
    Dev Biol; 1997 Feb; 182(1):21-32. PubMed ID: 9073440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FLASH acts as a co-activator of the transcription factor c-Myb and localizes to active RNA polymerase II foci.
    Alm-Kristiansen AH; Saether T; Matre V; Gilfillan S; Dahle O; Gabrielsen OS
    Oncogene; 2008 Aug; 27(34):4644-56. PubMed ID: 18408764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-Myb prevents growth arrest associated with terminal differentiation of monocytic cells.
    Bies J; Hoffman B; Amanullah A; Giese T; Wolff L
    Oncogene; 1996 Jan; 12(2):355-63. PubMed ID: 8570212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redundant functions of B-Myb and c-Myb in differentiating myeloid cells.
    Golay J; Broccoli V; Borleri GM; Erba E; Faretta M; Basilico L; Ying GG; Piccinini G; Shapiro LH; Lovrić J; Nawrath M; Mölling K; Rambaldi A; Introna M
    Cell Growth Differ; 1997 Dec; 8(12):1305-16. PubMed ID: 9419419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleoskeleton and nucleo-cytoplasmic transport in oocytes and early development of Xenopus laevis.
    Rudt F; Firmbach-Kraft I; Petersen M; Pieler T; Stick R
    Int J Dev Biol; 1996 Feb; 40(1):273-8. PubMed ID: 8735938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clast4, the murine homologue of human eIF4E-Transporter, is highly expressed in developing oocytes and post-translationally modified at meiotic maturation.
    Villaescusa JC; Allard P; Carminati E; Kontogiannea M; Talarico D; Blasi F; Farookhi R; Verrotti AC
    Gene; 2006 Feb; 367():101-9. PubMed ID: 16343815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-Myb overcomes a p107-mediated cell proliferation block by interacting with an N-terminal domain of p107.
    Joaquin M; Bessa M; Saville MK; Watson RJ
    Oncogene; 2002 Nov; 21(52):7923-32. PubMed ID: 12439743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.